Patients with Crohn’s disease who start on infliximab combined with an immunomodulator have far better outcomes within a year compared with traditional ‘step-up’ treatment, a…
Early ileocecal resection could be an effective first-line therapy for Crohn’s disease, according to Danish and US gastroenterologists, challenging the current paradigm of reserving surgery…
Patients responsive to  the IV formulation may find subcutaneous dosing more convenient, expert says.
But a large study finds a much lower benefit of monotherapy for patients with Crohn's disease.
Benefits were seen in steatosis, BMI and disease activity in the study.
Crohn's disease is more strongly linked than ulcerative colitis, results suggest.
Study finds patients diagnosed under 40 are most at risk.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
